Evidence map›Paper›PMID 24716825›Full record

ReviewExpert review of clinical pharmacology2014

Combination pharmacotherapies for stimulant use disorder: a review of clinical findings and recommendations for future research.

William W Stoops, Craig R Rush

Open access · greenAbstract readReview
In one paragraph

Review in Expert review of clinical pharmacology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
1.8field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 34 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Review
  4. Review
  5. Article
  6. Review
  7. Pharmacotherapy treatment of stimulant use disorder.The mental health clinician · 2021
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

William W StoopsDepartment of Behavioral Science, University of Kentucky, College of Medicine, Medical Behavioral Science Building, Lexington, KY 40536, USA.
Craig R Rush
University of Kentucky · US

Funding

A Novel Anti Obesity Drug Combination as a Pharmacotherapy for Cocaine DependenceR01DA032254 · NIDA · UNIVERSITY OF KENTUCKY · PI RUSH, CRAIG R · 2012 to 2015
$1.9M
Targeting GABA and Opioid Systems for a Pharmacotherapy for Methamphetamine AbuseR01DA033394 · NIDA · UNIVERSITY OF KENTUCKY · PI RUSH, CRAIG R · 2013 to 2015
$1.8M
NIDA NIH HHS R01 DA032254NIDA NIH HHS R01DA032254NIDA NIH HHS R01 DA033394NIDA NIH HHS R01DA033394
6 · The paper itself

Abstract

Despite concerted efforts to identify a pharmacotherapy for managing stimulant use disorders, no widely effective medications have been approved. Innovative strategies are necessary to develop successful pharmacotherapies for stimulant use disorders. This manuscript reviews human laboratory studies and clinical trials to determine whether one such strategy, use of combination pharmacotherapies, holds promise. The extant literature shows that combination pharmacotherapy produced results that were better than placebo treatment, especially with medications shown to have efficacy as monotherapies. However, many studies did not compare individual constituents to the combination treatment, making it impossible to determine whether combination treatment is more effective than monotherapy. Future research should systematically compare combined treatments with individual agents using medications showing some efficacy when tested alone.

Indexed as

Amphetamine-Related DisordersCentral Nervous System StimulantsClinical Trials as TopicCocaine-Related DisordersDrug Therapy, CombinationHumansPractice Guidelines as TopicTreatment OutcomeCentral Nervous System Stimulants

Identifiers

PMID24716825
PMCPMC4017926
OpenAlexW2035343906

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.